Clinical trials recruiting in Meishan, China
3
Recruiting trials
5
Conditions
Phase breakdown
Phase 2 1Phase 3 1Phase 4 1
Conditions recruiting in Meishan, China
| Condition | Trials |
|---|---|
| Chronic kidney disease | 2 |
| End Stage Renal Disease (ESRD) | 1 |
| Kidney Disease, Chronic | 1 |
| NASH | 1 |
| Non-alcoholic Steatohepatitis | 1 |
Recruiting trials in Meishan, China
- EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
- Efficacy and Safety of Recombinant Human FGF21-Fc Fusion Protein for Injection (TQA2225/AP025) in Adult Subjects With Non-alcoholic Steatohepatitis (NASH)
- Evaluate the Efficacy and Safety of Amino Acid (15) Peritoneal Dialysis Solution in Peritoneal Dialysis Patients with Malnutrition.
Common questions
How many clinical trials are recruiting in Meishan, China?
3 recruiting trials have at least one study site in Meishan, China.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.